Open radical prostatectomy (RRP) is the gold standard and most widespread treatment for clinically localized prostate cancer.H owever,i nr ecent years robot-assisted laparoscopic prostatectomy (RARP) is rapidly gaining acceptance among urologists worldwide. We sought to outline our surgical technique of robotic radical prostatectomy and provide practical recommendations based on available reports and personal experience. We also critically review the current experience on RARP worldwide and compare the available data with the gold standard open RRP series.
INTRODUCTION
Prostate cancer (CaP) is one of the most common cancers in Europe. Indeed, in the United Kingdom, it is the most common cancer in males accounting for approximately 24% of all new male cancer diagnoses (1). Despite some variability in CaP incidence amongst countries in Europe (Fig. 1) , over 300,000 have been added to the original technique (6, 7) the principle of local tumor control with less morbidity while preserving sexual function, has always been maintained. In this regard, efforts to duplicate the outcomes of RRP with less invasive techniques have been attempted.
One such option is robot-assisted laparoscopic radical prostatectomy (RARP) performed with the DaVinci system (Intuitive Surgical, Sunnyvale, CA). RARP has attracted the attention of urologists willing to more rapidly overcome the steep learning curve associated with laparoscopic radical prostatectomy (LRP) and take advantage of its superior three-dimensional (3D) vision, seven degrees of freedom of movement truly mimicking the movements made during standard open surgery, lack of tremor and far superior ergonomic compared to standard laparoscopy. These advantages favor the non-laparoscopic surgeon to easily achieve otherwise complex skills such as intracorporeal suturing and knot tying. Hence, RARP appears as the great equalizer between the highly skilled laparoscopic procedure and the widespread open technique. Indeed, RARP has evolved as an obvious next step of LRP,o nly to be constrained by the substantial initial capital investment and high maintenance costs (8).
Since the first RARP successfully performed Binder and Kramer in Germany in 2001 (9), robotic assistance has dramatically changed the surgical management of clinially localized prostate cancer. In this short period, RARP is now being utilized worldwide. In the United States, 41% of radical prostatectomies werep erformed with robot-assistance in 2006. This number increased to morethan 60% in 2007 and it is projected to be nearly 80% in 2008 (10) . More importantly,multiple RARP series arenow matureenough to demonstrate safety, efficiency and reproducibility of the procedure, as well as oncologic and functional outcomes comparable to its open counterpart (11) (12) (13) .
In the present manuscript we outline our surgical technique of robotic radical prostatectomy and provide practical recommendations based on available reports and personal experience. We also critically review the current experience on RARP worldwide and compare the available data with the gold standardopen RRP series.
MATERIAL AND METHODS
Areview of the literaturewas performed for all published manuscripts between 1997 and 2008 using the keywords -'robotic radical prostatectomy, 'robot*-assisted radical prostatectomy', 'laparoscopic radical prostatectomy' and 'robotic' using the Medline database. At otal of 226 original manuscripts on RARP werei dentified. Manuscripts were selected according to their relevance to the current topic (i.e. original articles, number of patients in the series, prospective data collection) and incorporated into this review.
RESULTS

DEVELOPMENT OF ASUCCESSFUL ROBOTIC PROGRAM
The establishment of a successful robotic program requires as tructured plan. We recently described a number of key components to implement a successful program (14) . These include an initial design, to evaluate the institution's ability to withstand initial and maintenance costs and later guarantee that consistent surgical volume will be available to support a robotic program (at least 3-5 cases/week). The appointment of ad edicated robotic program director and al ead surgeon are critical; the first, to act as liaison between hospital administrators and the different medical specialties involved, while the latter to directly develop the program and also encourage other specialties to incorporate robotic assistance to their practices, thus facilitating a more cost-effective approach. Implementation of a dedicated nursing and OR assistant team with thorough understanding of the procedure and its steps are also critical for success. Once the program is operational, marketing is a key component as the only financial support for increased costswill be new patient volume. Lastly,true success and durability of an oncologic program will depended on its long-term outcomes. As such, prospective data collection with analysis of validated questionnaires for functional outcomes is necessary.
LEARNING CURVE
Learning curve is adifficult tool to assess as thereis no accepted standard definition or mean to measure it. It is a "self-declared" point at which the surgeon feels comfortable performing the procedure ( 15) . As such, the learning curve can vary significantly according to surgeon-related factors including previous extensive experience performing open RRP but no laparoscopic background, or alternatively, extensive laparoscopic experience but limited oncologic training performing radical prostatectomies.
Some authors have tried to use operative (OR) time, estimated blood loss (EBL) and rate of complications as perioperative variables to define learning curve. Ahlering et al (16) reported that al earning curve to less than 4-hour proficiency was 12 cases. Similarly,Artibani et al (17) reported less than 4-hour proficiency after 16 cases and as ignificant decrease in transfusion rate after case number 10. Zorn et al (18) compared the first, second, and third 50 RARP cases performed by a highly experienced laparoscopic surgeon and found that mean OR time, EBL and conversion rate decreased significantly with increasing experience, with all conversion occurring during the first 25 cases. As reported previously (19) , we estimated that 20-25 cases were required to achieve technical proficiency.Avery dissimilar experience was reported by Herrel et al (15) . The authors found that although some outcomes after RARP were immediately equivalent to RRP,o verall experience was not comparable until after 150 cases. Further, the subjective confidence of the primary surgeon did not approach his level of confidence in RRP until >250 cases.
Adifferent angle for analysis of learning curve was reported by Steinberg et al (8) . Based on a constructed theoretical model analyzing leaning curves from 8 different centers, the authors demonstrated that the average learning curve was 77 cases, with an associated cost of over 200 thousand dollars.
SURGICAL TECHNIqUE
Most published RARP series follow the same basic principles with only subtle modifications. Positioning of the patient in extended lithotomy and steep Trendelenburg is the standard. Likewise, most series utilize the transperitoneal approach as it provides a larger working space, particularly important during lymph-node dissection and urethrovesical anastomosis (15) (16) (17) (18) (19) (20) . However, some series utilizing the extraperitoneal approach have beend escribed (21) (22) (23) . Proponents of this alternative route claim that advantages include ad ecreased risk for intra-abdominal complications such as bowel injury, postoperative ileus and development of incisional hernia. Still, the incidence of these complications has been estimated in less than 1% among large series (24) .
Our technique is based on standard laparoscopic (25) and robotic technique described previously by Menon et al (20) . However, after over 2700 cases performed, the procedure has evolved significantly, including several refinements to further improve surgical outcomes and reduce patient morbidity. We herein describe the surgical technique we currently perform at our institution.
Preoperative preparation
One hour prior to incision, the patient receives 1g IV cephazolin (1 st generation cephalosporin). Prior to induction of anesthesia, sequential compression devices are placed on the lower extremities and the patient receives 5000 units of subcutaneous heparin. At this point the patient is positioned in low lithotomy, ensuring that that thighs are not overextended to avoid neuropraxia of the lateral femoral cutaneous nerve. Both arms and hands areg ently padded and tacked to the OR table. The patient is held in place with the aid of a bean bag while in 20 degree Trendelenburgposition.
The hair from the abdomen is trimmed and the patient is prepped and draped in as terile fashion. Beforei nsufflation, an orogastic tube is placed as well as a1 6-French Foley catheter with 15cc in the balloon.
Intra-abdominal access and trocar placement
The transperitoneal approach is utilized in all cases and obtained via a1 cm supraumbilical incision. In most cases, a Ve ress needle is utilized and the abdomen is insufflated to 15 mmHg. Atotal of 6t rocars are placed as depicted in Fig. 2 and the robot is docked.
Surgical steps
Step 1: Incision of the peritoneum and entry into the space of Retzius Atransverse peritoneal incision is made through the median umbilical ligament ( Fig. 3 ) and extended on both sides in an inverted Ufashion to the level of the vasa deferentia. The assistant and the fourth arm provide the counter-traction. The peritoneum is dissected down to the pubic tubercle following the median umbilical ligaments laterally in direction to the vasa deferentia. It is important to dissect the peritoneum all the way up to the base of the vasa for optimum release of the bladder to allow tension-free vesico-urethral anastomosis.
Step 2: Incision of the endopelvic fascia (EPF) and identification of the dorsal venous complex (DVC)
Instruments
• Fourth arm: Prograsp • Assistant: Microfrance grasper and suction • Telescope: 0°binocular lens
The important landmarks are bladder neck, base of the prostate, levator ani muscles and apex of the prostate ( Fig. 4 ). Once adequate exposure has been obtained, the EPF is opened immediately lateral to the reflection of the pubo-prostatic ligaments bilaterally. The EPF is best opened at the base of the prostate using cold scissors. This is the area with the largest amount of space between the prostate and the levators and the point at which the prostate has most mobility.P roceeding from the base to the apex, the levator fibers are pushed off of the prostate until the DVC and urethra arevisualized ( Fig. 5 ). Dissect only that which is necessary to get in a good DVC stitch. Extensive dissection of the apex at this time can lead to unnecessary bleeding. The full apical dissection is best performed at the end of the procedure ( Fig. 6 ). The needle is pushed straight across at 90°a nd then the wrist is turned to curve around the apex of the prostate. At this point we prefer to use the slip knot to tie as it prevents the suturef rom loosening as it is tied. Asecond sutureisthen placed to suspend the urethra to the pubic bone and secondarily ligate the DVC. The DVC is encircled and then stabilized against the pubic bone along with theurethra ( Fig. 7 ).
Step The laparoscope is changed to a 30°down-facing lens for the BN dissection. Although some authors use 0°d egree scope throughout the case, we believe that this angled lens is optimal to see inferiorly and to visualize the correct planes. The key point here is to correctly identify the BN. One trick is to pull on the urethral catheter and visualize the balloon snagging against the prostate. However,this can be misleading after transurethral resection of prostate (TURP) or in the presence of a median lobe. The robotic arms also provide a moderate amount of visual and sensory feedback to facilitate localization of the boundaries. We find it most reliable to visually identify the area at which the fat extending from the bladder ends as it reaches the prostato-vesical junction (Fig. 8 ). The bladder is dissected off the prostate in the midline using as weeping motion of the monopolar scissor while visualizing the bladder fibers. The key is to stay in the midline to avoid lateral venous sinuses till the anterior bladder neck is opened and then dissect on either side of the bladder neck. Once the anterior urethra is divided, the Foley catheter is retracted out of the bladder using the fourth arm, and upward trac- tion is applied to expose the posterior bladder neck ( Fig. 9 )
Step The posterior BN dissection is generally considered to be the most challenging aspect of the operation for the novice robotic surgeon. The difficulty is in appreciating the posterior tissue plane between the bladder and prostate and the direction and depth of dissection necessary to locate the seminal vesicles. After incision of the anterior BN, any remaining peripheral bladder attachments should be divided to flatten out the area of the posterior bladder neck and allow precise visualization and dissection of the posterior plane. The full thickness of the posterior bladder neck should be incised at the precise junction between the prostate and the bladder (Fig. 10 ). The lip of the posterior BN is then grasped with the Maryland dissector and used for gentle traction to visualize the natural plane between the prostate and bladder.The dissection is directed posteriorly and slightly cephalad (towards the bladder) to expose the seminal vesicles. It is important to avoid dissecting caudally (towards the prostate) as there is a possibility of entering the prostate and missing the seminal vesicles completely.
Step Once the posterior BN dissection is complete, the vasa and SVs can be identified. The thin fascial layer over the SVs and vasa should be opened to free the structures for retraction. The fourth arm is used to retract the vasa superiorly ( Fig. 10 ). Both vasa are then incised, and the inferior portion of the vas is retracted by the assistant. The vasa are then followed posteriorly to expose the tips of the seminal vesicles ( Fig. 11 ). Aseminal artery is commonly found at the tip of the SV and is divided and clipped with a 5mm clip.
Step Dissection of the SVs has to be performed all the way to the base to allow for appropriate elevation of the prostate and identification of the Denonvillier's fascia ( Fig. 12 ). Denonvillier's fascia is thus opened at the base of the seminal vesicles. The correct plane can be identified by the presence of a clear pearly white plane that is relatively avascular between the posterior prostatic capsule and the rectum. When entered correctly, the plane is avascular and spreads easily with the Maryland dissector with minimal bleeding (Fig. 13 ).
Step Our approach to the nerve sparing portion is unique as we perform it in ar etrograde manner,m irroring the open approach. It is based upon the philosophy of minimal traction, use of no thermal energy,a nd early release of the neurovascular bundle with precise identificationo fi ts location at the base of the gland prior to ligating the prostatic pedicle (26) . Prior to performing this portion it is essential to maximally release the prostate from the rectum all the way to the apex and laterally to the bundles. Prior adequate ligation of the DVC is also key as this decompresses large periprostatic veins that can potentially be afrustrating source of bleeding.
For release of the left NVB, the assistant grasps the left lateral aspect of the base of the gland and rotates the prostate laterally to the right. When dissecting the right NVB the fourth arm is used instead of the assistant to rotate and elevate the prostate. With the prostate rotated laterally the lateral pelvic fascia is identified and early release of neurovascular bundle can then be performed. The levator fascia is elevated with the plasma kinetic forceps and incised along the lateral aspect of the prostate (Fig. 14) . At the level of the apex and midportion of the prostate the avascular plane between the neurovascular bundle and prostatic fascia is developed. As the plane is created the assistant keeps the suction tip in close proximity to provide a bloodless operative field. The plane is continued posteriorly between the neurovascular bundle and the prostatic fascia as an interfascial nerve-sparing dissection (Fig. 15 ). The NVB is stabilized with plasma kinetic forceps and the prostate is gently caressed medially away from the bundle. As the space between the bundle and prostate develops further, the assistant places the suction tip in this plane to assist with exposurea nd maintain ab loodless field. The dissection continues posteriorly to meet the plane of the posterior dissection between the prostate and rectum. The prostate is then stroked medially off of the bundle back to the base of the gland in a retrograde manner. No thermal energy is used during dissection of the bundle or ligation of the pedicle. The path of the bundle has now been clearly delineated and focus can now turn to controlling the prostatic vascular pedicle. The pedicle is controlled with a hemolock clip placed above the level of the already released bundle (Fig. 16 ). This technique allows complete neurovascular bundle sparing without the use of any thermal energy or trauma. The landmarks arethe ligated DVC, urethra, apex of the prostate and NVB. Again, it is essential to have securely ligated the DVC to prevent bleeding which may interferewith the apical dissection and division of the urethra under direct vision. Cold scissors are used to divide the DVC and along urethral stump is developed, as alonger urethral stump facilitates the anastomosis and may improve continence. Complete dissectionofthe apex and urethra is facilitated by the robotic magnification. The urethra is then incised at the apex of the prostate under direct vision to completely liberate the prostate (Fig. 17 ). Prior to performing the vesico-urethral anastomosis, we reconstruct the rabdho-sphincter posterior follow-ing the principles described by Rocco et al (27) . For this step, we use a 12 cm double arm 3/0 monocryl sutureo nR B1 needles. We proceed to identify the free edge of Denonvillier's fascia which is approximated to the posterior aspect of the rabdho-sphincter and posterior median raphe running one of the arms of the sutureand tied ( Fig. 18 ). Asecond layer is then run with the second arm of the suture, approximating a lip of posterior bladder tissue (approx 2 cm posterior to the BN) to the initial reconstructed layer,and the suture is tied (28) . Ac ontinuous modified Van Ve lthoven (29) vesico-urethral anastomosis is then performed. Two17cm3-0 Monocryl sutures on RB1 needles of different colors aret ied together with 10 knots to provide ab olster for the anastomosis. The posterior urethral anastomosis is performed first with one arm of the suture. Three passes are made through the bladder and two passes through the urethra and the suture is pulled straight up in order to bring the bladder down. The posterior anastomosis is continued in a clockwise direction from the 5 to 9 o'clock position obtaining adequate bites of tissue (Fig. 19 ). This is followed by completion of the anterior anastomosis with the second arm of the suture in a counterclockwise fashion.
The key to performing quick watertight anastomosis is to have an adequate urethral length, normalsized bladder neck, clear operative field and perineal pressure. Before the end of the procedure, a 20F Foley catheter is placed and saline is irrigated to confirm watertight anastomosis. AJ ackson-Pratt drain is placed around the anastomosis and all the trocars are removed under direct vision.
ONCOLOGIC OUTCOMES
As RARP has only been performed since 2001, longterm follow up to assess disease free survival (DFS) is lacking. Nevertheless, the 7-year intermediate-term available data still permit to obtain meaningful observations regarding important surrogate variables of DFS like biochemical recurrence (BR) and incidence of positive surgical margins (PSM). Although somewhat controversial, surgical margin status is generally recognized to be an independent risk factor for recurrence after radical prostatectomy,a nd it is the only factor that can be modified by surgical technique. Orvieto et al (30) demonstrated that PSM status, pathologic stage and Gleason grade weret he strongest predictors of BR on multivariate analysis after RRP.PSM rates vary widely among series, with lowest incidence rates coming from academic institutions (30, 31) , in which large volume of cases are performed. Thus, it seems that experience and careful attention to surgical technique also play a significant role in decreasing the incidence of PSM. These findings have also been supported by RARP series. We reported a PSM rate of 5.7% for organ confined disease after our initial 200 cases, but this number decreased to 2.5% after 500 consecutive cases (32) . Similarly, Ahlering et al reported an initial PSM rate of 27.3% for organ confined disease after their first 50 robotic cases, but this decreased to 4.7% after experience with 150 cases (33) .
In addition to learning curve, modifications in the surgical technique have been described in an effort to reduce PSM during RARP. Ahlering et al (33) reported that dissecting the periprostatic fat to expose the prostatic apex, and the use of a vascular stapler to control the dorsal venous complex (DVC) were specific surgical maneuvers responsible for reducing the risk of PSM. Guru et al (34) recommended cold incision of the DVC before suture ligation to reduce the rate of apical margin involvement. Zorn at el reported a striking 52% reduction of their postero-lateral pT3 PSMs by performing ap lanned side-specific nerve sparing protocol for patients undergoing RARP (12) .
The risk of aP SM also depends on clinical and pathological features, e.g. stage, preoperative PSA level and Gleason sum (35) . Liss et al (36) analyzed risk factors for aP SM during RARP and identified preoperative PSA level >10n g/ml, PSA density >0.15, pathological stage and Gleason grade as the most important risk factors for aPSM. Shikanov et al (37) reported on 70 patients with preoperative Gleason score 8-10 that underwent RARP as single treatment for their prostate cancer. The authors found that 53% of these patients had extracapsular extension with a PSM rate of 42.3% compared to 6% for those who had pT2 disease. They also demonstrated that a preoperative PSA< 10 ng/ml and a maximal core involvement <30% weresignificant predictors for more favorable outcomes. Table 1 summarizes the incidence of PSMs and biochemical recurrence on large contemporary RARP series. Berryhill et al reviewed 22 radical prostatectomy series and found that the average PSM for robotic, laparoscopic and open radical prostatectomies were 10.3%, 20.2% and 18.3%, respectively (38) . Similarly,E l-Hakim et al based on apooled analysis of the literature, reported an overall PSM rate of 15% for RARP compared to 20% for LRP and 24% for RRP (39) .
CONTINENCE OUTCOMES
Objective evaluation of urinary continence outcomes after radical prostatectomy remains stalled by the lack of standardization among series. Although validated tools andq uestionnaires area vailable, wide acceptance among many high-volume surgeons has been difficult. As such the literature is flooded with a plethora of "personal" definitions of continence such as "0 to 1pads", "pad for security reasons", "socially dry", etc., only to obscure the issue of true continence, making it nearly impossible to adequately analyze and compare. Moreover,i ti sa ccepted that patient and surgeon-reported outcomes vary considerably, yet surgeon-reported outcomes aret he most commonly used variable.
By using the criterion of no pads or one security pad to define continence, most laparoscopic and RARP series informingly report excellent outcomes of 90-95% (11) (12) (13) . However, with a lack of prospective randomized trials comparing these outcomes to RRP,meaningful conclusions whether any particular approach to radical prostatectomy delivers better continence outcomes are impractical.
In an effort to improve continence outcomes and especially to achieve earlier recovery of continence, many modifications have been introduced. We recently reported our preliminary results on early return of continence after incorporating the posterior reconstruction of the rabdho-sphincter as first described by Rocco et al (27) . The authors found an early continence rate at 1week of 58% as defined by the use of no pads (28) . Tewari et al (40) described an anterior and posterior reconstruction technique and compared their outcomes to previous patients from their series in which no reconstruction or posterior reconstruction only had been performed. Across the boards, patients who received total reconstruction did better,w ith continence rates of 38%, 83%, 91%, and 97% at 1, 6, 12, and 24 weeks, respectively. Opposite results werereported by Menon et al (41) . The authors found no improvement in early continence rates with reconstruction of the anterior and posterior periprostatic tissues. However, they did notice a major decrease in the incidence of urinary leak, which is aknown risk factor for developing bladder neck contracture and urinary incontinence.
POTENCy OUTCOMES
With younger and healthier men being diagnosed andtreatedfor localized prostate cancer,postradical prostatectomy erectile dysfunction (ED) has become an ever more important matter of debate. However, similar to continence data, a definition of potency has not been standardized. Moreover, there is still no consensus regarding the optimal instrument for assessing recovery of erectile function after prostatectomy, making comparison between different series extremely difficult. With this limitation in mind, potency rates from large published robotic series are uniformly excellent, exceeding 75-80% at 12 months postoperatively (11) (12) (13) .
Although nerve preservation can be achieved, injury of the neurovascular bundles (NVB) via excessive traction (causing neuropraxia) or heat-related trauma can occur intraoperatively. In this regard, different studies have addressed the importance of surgical technique during NVB. Ahlering et al (42) men undergoing RARP when an "athermal" technique was used compared to the standard NVBs dissection with the use of bipolar electrocautery.Similar results werer eported by the Cleveland Clinic group using a "bulldog technique" when performing LRP (43) . Our group (26) described an ovel athermal but retrograde release of the NVBs during RARP. We believe that this approach allows the surgeon to more clearly delineate the path of the bundle and avoid inadvertently injuring it when controlling the prostatic pedicle.
TRIFECTAOUTCOMES
After radical prostatectomy,t herea re 3l ong-term goals that have to be achieved; cancer control, return of continence and return of potency. This has led to the concept of reporting the likelihood of achieving these 3 outcomes concurrently, the so called "Trifecta". This term originates from horse racing, where Trifecta is a bet in which horses finishing first, second, and third must be predicted. Few series have reported Trifecta outcomes after RP (Table 2) with rates ranging between 20-76%. Salomon et al first reported Trifecta rate of 20% in their series of 205 patients 1year after open, laparoscopic and perineal prostatectomy (44) . Of note, individually,P SA free survival, continence and potency rates were 85%, 66% and 33%, respectively.Bianco et al reported aT rifecta rate of 60% at 2y ears after RRP (45) . Morer ecently, Eastham et al described their Trifecta rate at 62% at 2 years (46) . Only one report of outcomes in RARP patients is available. Orvieto et al (47) evaluated a homogenous cohort of preoperatively potent and continent men undergoing RARP with bilateral nerve sparing. All the patients had at least 1year follow-up.
Continence and potency data wereobtained with the use of validated questionnaire. In this series the Trifecta outcomes were7 1% and 76% at 1a nd 2y ears after the surgery,r espectively.I td ropped to 44% while morestrict and questionnaire-based functional outcomes definitions were applied. The authors concluded that RARP provides Trifecta outcomes rates at least comparable to open surgery. Thereissignificant difference in Trifecta outcomes depending upon continence and potency definitions and whether functional outcomes evaluation is based upon information derived from patient-surgeon encounter or self-administered validated questionnaire. In order to obtain realistic and comparable Trifecta outcomes analysis strict and uniform criteria for postoperative potency and continence should be defined.
CONCLUSIONS
After almost three decades of refinement in the surgical technique and accumulating experience, RRP has likely achieved its highest potential. Thereisnodoubt that both oncologic and functional outcomes derived from large-volume institutions performing RRP are excellent. However,t herei sd efinitely still room for improving outcomes when managing patients with localized prostate cancer.T he question is whether RRP outcomes can still be improved. Only 8y ears after the first RARP was performed, multiple large series arematureenough to demonstrate outcomes at least comparable to the most experienced open centers. The question again is whether RARP outcomes can be improved. Only over the last 3 months, five manuscripts specifically addressing surgical modifi-cations during RARP have been published in the literature. This underscorest hat the surgical technique for RARP continues to evolve, with further improvement of oncologic and functional outcomes.
In order to draw more decisive conclusions, however, significant efforts have to be made in order to perform prospective, randomized studies comparing both surgical techniques. Additionally, it is key that standardized definitions for continence and potency outcomes become available. Until then, the role of RARP will remain under close scrutiny.
